Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma

Lina Y Dimberg1, Anna Dimberg, Karolina Ivarsson

  • 1Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, S- 751 85, Sweden.

BMC Cancer
|July 31, 2012
PubMed
Abstract

Insights

Signal transducer and activator of transcription (Stat)1 activation in multiple myeloma (MM) cells alters IL-6 induced Stat3 activity and pro-apoptotic gene expression. However, Stat1 alone does not sensitize MM cells to apoptosis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Immunology

Background:

  • Multiple myeloma (MM) is an incurable blood cancer with apoptosis-resistant tumor cells.
  • Interferon (IFN) treatment can sensitize MM cells to apoptosis and increases Signal transducer and activator of transcription (Stat)1 activation.
  • Stat1 is proposed to have a pro-apoptotic role, while IL-6 induction of Stat3 confers apoptosis resistance in MM.

Purpose of the Study:

  • To investigate the role of Stat1 in IFN-mediated sensitization to apoptosis in MM.
  • To determine how Stat1 activation influences Stat3 signaling and apoptosis-related gene expression.
  • To assess if Stat1 activation alone is sufficient to sensitize MM cells to apoptosis.

Main Methods:

  • Established U-266-1970 MM cell lines with stable expression of active mutant Stat1C.
  • Analyzed the impact of Stat1C on endogenous Stat3 expression/activation and apoptosis-related genes.
  • Utilized high-throughput compound screening (HTS) on Stat1C-expressing and control cells.

Main Results:

  • Constitutive Stat1 activation attenuated IL-6-induced Stat3 activation.
  • Up-regulation of pro-apoptotic genes (Harakiri, Mcl-1 short form, Noxa) was observed with Stat1 activation.
  • Stat1 activation alone did not sensitize cells to Fas-induced apoptosis, and drug responses were largely unaltered.

Conclusions:

  • Stat1 activation modulates IL-6/Stat3 signaling and pro-apoptotic gene expression in MM.
  • Stat1-mediated changes alone are insufficient to induce apoptosis sensitivity in MM cells.
  • Stat1-independent pathways likely contribute to IFN-mediated apoptosis sensitization in MM.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.